De Novo Multi-Omics Pathway Analysis Designed for Prior Data Independent Inference of Cell Signaling Pathways
Katri Vaparanta(Åbo Akademi University), Klaus Elenius(Åbo Akademi University)
Cited by 2
Related Papers
Signaling via ErbB2 and ErbB3 Associates with Resistance and <i>Epidermal Growth Factor Receptor</i> (<i>EGFR</i>) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells
|Clinical Cancer Research|2006|265
Interaction with ErbB4 Promotes Hypoxia-inducible Factor-1α Signaling
|Journal of Biological Chemistry|2012|44
An unbiased in vitro screen for activating epidermal growth factor receptor mutations
|Journal of Biological Chemistry|2019|28
The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration
|Journal of Biological Chemistry|2020|17
Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin
|Scientific Reports|2018|11